Affinity of tomopenem (CS-023) for penicillin-binding proteins in Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 3, 2009, Pages 1238-1241

  Koga, Tetsufumi ^a   Sugihara, Chika ^a   Kakuta, Masayo ^a   Masuda, Nobuhisa ^a   Namba, Eiko ^a   Fukuoka, Takashi ^a  

^a DAIICHI SANKYO CO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMIPENEM; MEROPENEM; PENICILLIN BINDING PROTEIN; TOMOPENEM;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM CULTURE; CONTROLLED STUDY; DRUG BINDING; ESCHERICHIA COLI; MORPHOLOGY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

CARBAPENEMS; ESCHERICHIA COLI; MICROBIAL SENSITIVITY TESTS; MUTATION; PENICILLIN-BINDING PROTEINS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

EID: 62949244999     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01433-08     Document Type: Article

References (17)

1. Cornaglia, G., L. Guan, R. Fontana, and S. Satta. 1992. Diffusion of meropenem and imipenem through the outer membrane of Escherichia coli K-12 and correlation with their antibacterial activities. Antimicrob. Agents Chemother. 36:1902-1908.
2. Davies, T. A., W. Shang, K. Bush, and R. K. Flamm. 2008. Affinity of doripenem and comparators to penicillin-binding proteins in Escherichia coli and Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 52:1510-1512.
3. Georges, B., J. M. Conil, A. Dubouix., M. Archambaud, E. Bonnet, S. Saivin, V. Lauwers-Cances, C. Cristini, P. Cougot, J. F. Decun, O. Mathe, G. Chabanon, N. Marty, T. Seguin, and G. Houin. 2006. Risk of emergence of Pseudomonas aeruginosa resistance to β-lactam antibiotics in intensive care units. Crit. Care Med. 34:1636-1641.
4. Irfan, S., F. Idrees, V. Mehraj, F. Habib, S. Adil, and R. Hasan. 2008. Emergence of Carbapenem resistant Gram negative and vancomycin resistant Gram positive organisms in bacteremic isolates of febrile neutropenic patients: a descriptive study. BMC Infect. Dis. 8:80.
5. Koga, T., T. Abe, H. Inoue, T. Takenouchi, A. Kitayama, T. Yoshida, N. Masuda, C. Sugihara, M. Kakuta, M. Nakagawa, Y. Utsui, T. Fukuoka, and S. Kuwahara. 2005. In vitro and in vivo antibacterial activity of CS-023 (RO4908463), a novel parenteral carbapenem. Antimicrob. Agents Chemother. 49:3239-3250.
6. Koga, T., N. Masuda, C. Sugihara, M. Kakuta, and T. Fukuoka. 2008. Potent in vitro activity of tomopenem (CS-023) against methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 52:2849-2854.
7. Lepper, P. M., E. Grusa, H. Reichl, J. Högel, and M. Trautmann. 2002. Consumption of imipenem correlates with β-lactam resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 46:2920-2925.
8. Masuda, N., and S. Ohya. 1992. Cross-resistance to meropenem, cephems, and quinolones in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 36:1847-1851.
9. Masuda, N., T. Takenouchi, M. Kakuta, C. Ichii, E. Sakagawa, T. Abe, Y. Utsui, S. Ohya, and S. Kuwahara. 2000. R-115685, a novel parenteral carbapenem: mode of action and resistance mechanisms, abstr. F-1231, p. 204. Abstr. 40th Intersci. Conf. Antimicrob. Agents Chemother. American Society for Microbiology, Washington, DC.
10. National Committee for Clinical Laboratory Standards. 1999. Methods for determining bactericidal activity of antimicrobial agents. Approved guideline M26-A. National Committee for Clinical Laboratory Standards, Wayne, PA.
11. National Committee for Clinical Laboratory Standards. 2000. Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically, 5th ed. Approved standard, M7-A5. National Committee for Clinical Laboratory Standards, Wayne, PA.
12. Neuwirth, C., E. Siebor, J. M. Duez, A. Pechinot, and A. Kazmierczak. 1995. Imipenem resistance in clinical isolates of Proteus mirabilis associated with alterations in penicillin-binding proteins. J. Antimicrob. Chemother. 36:335-342.
13. Spratt, B. G. 1975. Distinct penicillin binding proteins involved in the division, elongation, and shape of Escherichia coli K12. Proc. Natl. Acad. Sci. USA 72:2999-3003.
14. Sumita, Y., M. Fukasawa, and T. Okuda. 1990. Comparison of two carbapenems, SM-7338 and imipenem: affinities for penicillin-binding proteins and morphological changes. J. Antibiot. 43:314-320.
15. Utsui, Y., and T. Yokota. 1985. Role of an altered penicillin-binding protein in methicillin- and cephem-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 28:397-403.
16. Wise, E. M., Jr., and J. T. Park. 1965. Penicillin: its basic site of actionas an inhibitor of a peptide cross-linking reaction in cell wall mucopeptide synthesis. Proc. Natl. Acad. Sci. USA 54:75-81.
17. Zhao, G., T. I. Mesiser, S. D. Kahl, K. R. Gee, and L. C. Blaszczak. 1999. BOCILLIN FL, a sensitive and commercially available reagent for detection of penicillin-binding proteins. Antimicrob. Agents Chemother. 43:1124-1128.